English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew ACG Clinical Guidelines on the management of acute pancreatitis are featured in the March 2024 issue of AJG
Tag: The American Journal of Gastroenterology
The Rising Costs of Alcohol-Associated Liver Disease and More in the February Issue of AJG
A modeling study projecting the economic and social burden of alcohol-associated liver disease by 2040 is featured in the February 2024 issue of AJG, just one month after the new ACG Clinical Guideline on Alcohol-Associated Liver Disease
Studies on Higher Infliximab Concentrations in IBD, Opioid-Related Constipation and More in the November Issue of AJG
The November issue of AJG highlights new clinical science and reviews including additional colonoscopy quality measures, higher infliximab concentrations in IBD patients with higher visceral adipose tissue (VAT), an automated tissue systems pathology test for Barrett’s esophagus, and opioid-related constipation.
New “Guide to the Guidelines” Publication Offers Practical Advice for Implementing ACG Clinical Guidelines
This new publication, introduced at the ACG 2023 Annual Scientific Meeting, provides clinical vignettes to demonstrate the practical application of ACG Clinical Guidelines.
April Issue of AJG Discusses Colorectal Cancer Risk Factors, H. pylori Infection, and Crohn’s Therapies
The April issue of The American Journal of Gastroenterology highlights new clinical science, including an examination of changes in lifestyle habits and risk of colorectal cancer
February Issue of AJG Features New Guideline on Acute Lower GI Bleeding
The February issue of The American Journal of Gastroenterology features a new ACG Clinical Guideline on Acute Lower GI Bleeding, a common reason for hospitalization in digestive diseases, which can be challenging to assess and triage.
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors (PPIs)
Findings from an online survey of more than 53,000 American adults suggest that using heartburn medications known as proton pump inhibitors (PPIs) once or twice daily significantly increases the odds of a positive test for COVID-19 compared to those who do not take PPIs. This research appeared online July 7, 2020 in pre-print format in The American Journal of Gastroenterology.
Digestive Symptoms Are Prominent Among COVID-19 Patients Reveals Study in The American Journal of Gastroenterology
The American Journal of Gastroenterology published today a new study that reveals digestive symptoms, including diarrhea, are common in COVID-19 patients. The study comes from the Wuhan Medical Treatment Expert Group for COVID-19 in China. Nearly half of COVID-19 patients…